Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Zi-Jian Deng"'
Autor:
Zi-Jian Deng, Run-Cong Nie, Jun Lu, Xi-Jie Chen, Jun Xiang, Chang-Ming Huang, Ying-Bo Chen, Jun-Sheng Peng, Shi Chen
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Objective The benefit of adjuvant chemotherapy is still controversial for stage II gastric cancer patients. This study aims to identify prognostic factors to guide individualized treatment for stage II gastric cancer patients. Methods We ret
Externí odkaz:
https://doaj.org/article/ac6b752abd65436588110d597ade8fab
Autor:
Li-Ying OuYang, Zi-Jian Deng, Yu-Feng You, Jia-Ming Fang, Xi-Jie Chen, Jun-Jie Liu, Xian-Zhe Li, Lei Lian, Shi Chen
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundEsophagogastric junction adenocarcinoma (EGJA) is a special malignant tumor with unknown biological behavior. PD-1 checkpoint inhibitors have been recommended as first-line treatment for advanced EGJA patients. However, the biomarkers for p
Externí odkaz:
https://doaj.org/article/f1d268a71b8746808038212dc846ad98
Autor:
Yong-He Chen, Jun Lu, Run-Cong Nie, Dan Liu, Ai-Hong Liu, Zi-Jian Deng, Xi-Jie Chen, Jun Xiang, Ying-Bo Chen, Chang-Ming Huang, Shi Chen, Jun-Sheng Peng
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundAccording to the 8th edition AJCC staging manual, a least of 16 lymph nodes retrieval (LNRs) is the minimal requirement for lymph nodes (LNs) dissection of gastric cancer surgery. Previous studies have shown that increasing the number of LN
Externí odkaz:
https://doaj.org/article/c67acae40b5f4f5eabc5c643d54ed3f2
Autor:
Chuang Gao, Zi-Jian Deng, Dong Peng, Yu-Shen Jin, Yan Ma, Yan-Yan Li, Yu-Kun Zhu, Jian-Zhong Xi, Jie Tian, Zhi-Fei Dai, Chang-Hui Li, Xiao-Long Liang
Publikováno v:
Cancer Biology & Medicine, Vol 13, Iss 3, Pp 349-359 (2016)
Objective: Photoacoustic (PA) tomography (PAT) has attracted extensive interest because of its optical absorption contrast and ultrasonic detection. This study aims to develop a biocompatible and biodegradable PA contrast agent particularly promising
Externí odkaz:
https://doaj.org/article/29836ad95cc94b69bc2a331d5d84d31d
Publikováno v:
Clinical Colorectal Cancer; Mar2024, Vol. 23 Issue 1, p104-110, 7p
Publikováno v:
Nuclear Science and Techniques. 34
Autor:
Junsheng Peng, Xi-Jie Chen, Zi-Jian Deng, Jun Xiang, Run-Cong Nie, Shi Chen, Jun Lu, Chang-Ming Huang, Yingbo Chen
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Gastroenterology
BMC Gastroenterology
Objective The benefit of adjuvant chemotherapy is still controversial for stage II gastric cancer patients. This study aims to identify prognostic factors to guide individualized treatment for stage II gastric cancer patients. Methods We retrospectiv
Autor:
Jia-Ming Fang, Runcong Nie, Jun Lu, Zi-Jian Deng, Xian-Zhe Li, Xi-Jie Chen, Jun-Jie Liu, Lei Lian, Jun-Sheng Peng, Shi Chen
Publikováno v:
SSRN Electronic Journal.
Background: Gastric cancer is the fourth most common malignant disease. Both CDK10 and long noncoding RNAs (lncRNAs) have been found to exert biological functions in multiple cancers. However, it is still unclear whether CDK10 represses tumor progres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e539919c7a3b52c5803b51f4d5762b5
https://doi.org/10.21203/rs.3.rs-610700/v1
https://doi.org/10.21203/rs.3.rs-610700/v1
Autor:
Jun Xiang, Shi Chen, Run-Cong Nie, Xi-Jie Chen, Zi-Jian Deng, Jun Lu, Yingbo Chen, Jun-Sheng Peng, Chang-ming Huang
Objective: The benefit of adjuvant chemotherapy is still controversial for stage II gastric cancer patients. This study aims to identify prognostic factors to guide individualized treatment for stage II gastric cancer patients.Methods: We retrospecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::304682ef58499fec681cd7ef5f0fd839
https://doi.org/10.21203/rs.3.rs-143889/v1
https://doi.org/10.21203/rs.3.rs-143889/v1